Meiogenix

Revolutionizing plant breeding for a sustainable future

Meiogenix is headquartered in Durham, United States, lists 11–50 employees, and has $13.0M in recorded funding across 1 round.

Employees
11–50
Business Model
B2B
Total Funding
$13.0M
Last Round
$13.0M Series AMay 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

Meiogenix is an agricultural biotechnology company developing AI-powered precision breeding technologies based on targeted chromosome recombination to accelerate crop improvement. By unlocking natural genetic diversity that traditional breeding methods cannot access, Meiogenix enables seed companies and plant breeders to deliver elite crop varieties with enhanced disease resistance, stress tolerance, and productivity. The company offers technology licensing partnerships and crop innovation programs for both specialty crops (tomato, fruits, vegetables) and major field crops (corn, rice, wheat, soybean). Meiogenix has US headquarters in Durham, North Carolina and offices in Paris, France.

Summary

Meiogenix is a Biotech company based in Durham, United States. It lists 11–50 employees. It has raised $13.0M in total across 1 round, most recently a $13.0M Series A round in May 2022. Investors include Sofinnova Partners, Genoa Ventures and Bpifrance.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2022
$13.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Meiogenix on Indexed.vc
<a href="https://indexed.vc/companies/meiogenix"><img src="https://indexed.vc/api/badge/company/meiogenix" alt="Meiogenix on Indexed.vc" width="260" height="76" /></a>